SGLT2 抑制剂与发生癌症的关联
Yuta Suzuki1, Hidehiro Kaneko2, Akira Okada3
1The Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan; Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Saitama, Japan.
Diabetes & metabolism
|October 25, 2024
概括
-葡萄糖携带载体2抑制剂 (SGLT2i) 可能会降低糖尿病患者的癌症风险. 这项研究发现,与DPP4抑制剂相比,SGLT2i的使用与较低的癌症发病率有关.
科学领域:
- 心血管医学 心血管医学
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
背景情况:
- -葡萄糖共运输体2抑制剂 (SGLT2i) 与癌症发病率之间的关联尚未得到充分证实.
- 糖尿病是众所周知的各种癌症的风险因素.
研究的目的:
- 研究SGLT2抑制剂与糖尿病患者发生癌症的风险之间的潜在关联.
- 为了比较患者新处方的SGLT2抑制剂与二乙酶4抑制剂之间的癌症发病率.
主要方法:
- 一个大规模的全国性流行病学数据库被用于分析.
- 使用倾向分数匹配,创建可比的SGLT2i和DPP4i用户队列.
- 癌症发病率是主要结局,平均随访时间为2.0年.
主要成果:
- 使用SGLT2抑制剂与整体癌症发病率显著降低的风险相关 (HR 0.80,95% CI 0.70-0.91).
- 随着SGLT2i的使用 (HR 0.71,95% CI 0.50-0.998) 观察到结直肠癌风险显著降低.
- 结果在多个灵敏度分析中都是稳定的,包括重叠权重和治疗权重的逆概率.
结论:
- 现实世界的数据表明,SGLT2抑制剂可能对糖尿病患者的癌症发展提供保护作用.
- SGLT2 抑制剂在降低癌症风险方面显示出与 DPP4 抑制剂相比的潜在优势.
- 需要进一步的研究来阐明这种观察到的关联背后的机制.
相关概念视频
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
176
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
176
01:23Dipeptidyl Peptidase 4 Inhibitors
173
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
173
01:27Glucose Transporters
22.5K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.5K
01:24Glucagon-like Receptor Agonists
301
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
301
01:17Oral Hypoglycemic Agents: Sulfonylureas
193
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
193
02:59Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K